首页> 美国卫生研究院文献>Autophagy >BLOC1S1/GCN5L1/BORCS1 is a critical mediator for the initiation of autolysosomal tubulation
【2h】

BLOC1S1/GCN5L1/BORCS1 is a critical mediator for the initiation of autolysosomal tubulation

机译:BLOC1S1/GCN5L1/BORCS1 是自体溶酶体输管起始的关键介质

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The mechanisms orchestrating recycling of lysosomes through autophagic lysosome reformation (ALR) is incompletely understood. Previous data show that genetic depletion of BLOC1S1/GCN5L1/BORCS1 increases autolysosome (AL) accumulation. We postulated that this phenotype may manifest due to perturbed ALR. We explored this in control and bloc1s1 liver-specific knockout (LKO) mouse hepatocytes, showing that in response to nutrient-deprivation LKO’s fail to initiate ALR due to blunted lysosomal tubulation. As kinesin motor proteins and the intracellular cytoskeleton are requirements for tubular formation from ALs, we explored the interaction of BLOC1S1 with motor proteins and cytoskeletal factors. BLOC1S1 interacts with the ARL8B-KIF5B (GTPase and kinesin motor protein) complex to recruit KIF5B to ALs. Furthermore, BLOC1S1 interacts with the actin nucleation promoting factor WHAMM, which is an essential structural protein in the initiation of lysosomal tubulation (LT). Interestingly, the genetic reintroduction of BLOC1S1 rescues LT in LKO hepatocytes, but not when KIF5B is concurrently depleted. Finally, given the central role of MTORC1 signaling in ALR initiation, it was interesting that MTORC1 activity was increased despite the absence of LT in LKO hepatocytes. Concurrently, inhibition of MTORC1 abolished BLOC1S1 reconstitution-mediated rescue of LT in LKO hepatocytes. Taken together these data demonstrate that the functional interaction of BLOC1S1 with the kinesin binding complex and the actin cytoskeleton are a requirement for LT which, in parallel with MTORC1 signaling, initiate lysosome recycling via ALR.Abbreviations: 3-MA: 3-methyladenine; AL: autolysosome; ALR: autophagic lysosome reformation; ARL8B: ADP-ribosylation factor-like protein 8B; ARPC2: actin related protein 2/3 complex, subunit 2; ATAT1/αTAT1: alpha tubulin acetyltransferase 1; AVd: autophagic vacuoles, degradative; BLOC1S1/GCN5L1: biogenesis of lysosomal organelles complex-1, subunit 1; CQ: chloroquine; KIF5B: kinesin family member 5B; KLC1: kinesin light chain 1; LAMP1: lysosomal-associated membrane protein 1; LAMP2: lysosomal-associated membrane protein 2; LC3B-I: cytosolic form of LC3B; LC3B-II: lipidated form of LC3B; MAP1LC3B/LC3B: microtubule-associated protein 1 light chain 3 beta; LKO: liver-specific knockout; LIs: lysosome inhibitors; LT: lysosomal tubulation; Ly: lysosome; MTORC1: mechanistic target of rapamycin kinase complex 1; PLEKHM2/SKIP: pleckstrin homology domain containing, family M (with RUN domain) member 2; Snapin: SNAP-associated protein; SQSTM1/p62: sequestosome 1; SVPs: synaptic vesicle precursors; TFEB: transcription Factor EB; TFE3: transcription factor E3; WHAMM: WAS protein homolog associated with actin, golgi membranes and microtubules.
机译:通过自噬溶酶体重组 (ALR) 协调溶酶体循环的机制尚不完全清楚。以前的数据显示,BLOC1S1/GCN5L1/BORCS1 的基因耗竭增加了自溶酶体 (AL) 的积累。我们假设这种表型可能是由于 ALR 扰动而表现出来的。我们在对照和 bloc1s1 肝脏特异性敲除 (LKO) 小鼠肝细胞中对此进行了探索,表明在响应营养剥夺时,LKO 由于溶酶体肾小管变钝而无法启动 ALR。由于驱动蛋白运动蛋白和细胞内细胞骨架是从 AL 形成肾小管的要求,因此我们探索了BLOC1S1与运动蛋白和细胞骨架因子的相互作用。BLOC1S1 与 ARL8B-KIF5B (GTP 酶和驱动蛋白运动蛋白) 复合物相互作用,将 KIF5B 募集到 AL 中。此外,BLOC1S1 与肌动蛋白成核促进因子 WHAMM 相互作用,WHAMM 是溶酶体肾小管形成 (LT) 启动中的重要结构蛋白。有趣的是,BLOC1S1 的基因重新引入在 LKO 肝细胞中挽救了 LT,但当 KIF5B 同时耗尽时则不然。最后,鉴于 MTORC1 信号转导在 ALR 起始中的核心作用,有趣的是,尽管 LKO 肝细胞中不存在 LT,但 MTORC1 活性增加。同时,MTORC1 的抑制消除了 LKO 肝细胞中重建介导BLOC1S1 LT 的挽救。综上所述,这些数据表明,BLOC1S1 与驱动蛋白结合复合物和肌动蛋白细胞骨架的功能相互作用是 LT 的要求,它与 MTORC1 信号转导平行,通过 ALR 启动溶酶体再循环。缩写: 3-MA: 3-甲基腺嘌呤;AL: 自溶酶体;ALR: 自噬溶酶体改革;ARL8B: ADP-核糖基化因子样蛋白 8B;ARPC2: 肌动蛋白相关蛋白 2/3 复合物,亚基 2;ATAT1/αTAT1: α 微管蛋白乙酰转移酶 1;AVd: 自噬液泡,降解性;BLOC1S1/GCN5L1: 溶酶体细胞器复合物 1 的生物发生,亚基 1;CQ: 氯喹;KIF5B: 驱动蛋白家族成员 5B;KLC1: 驱动蛋白轻链 1;LAMP1: 溶酶体相关膜蛋白 1;LAMP2: 溶酶体相关膜蛋白 2;LC3B-I: LC3B 的胞质形式;LC3B-II: LC3B 的脂质化形式;MAP1LC3B/LC3B: 微管相关蛋白 1 轻链 3 β;LKO: 肝脏特异性敲除;LIs: 溶酶体抑制剂;LT: 溶酶体肾小管;Ly:溶酶体;MTORC1: 雷帕霉素激酶复合物 1 的机制靶标;PLEKHM2/SKIP:包含普列克底物素同源结构域,家族 M(具有 RUN 结构域)成员 2;Snapin:SNAP 相关蛋白;SQSTM1/p62: 螯合体 1;SVPs:突触小泡前体;TFEB: 转录因子 EB;TFE3: 转录因子 E3;WHAMM:与肌动蛋白、高尔基体膜和微管相关的 WAS 蛋白同源物。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号